Polymorphisms in DNA damage binding protein 2 (DDB2) and susceptibility of primary lung cancer in the Chinese: a case-control study - PubMed (original) (raw)
. 2006 Jul;27(7):1475-80.
doi: 10.1093/carcin/bgi350. Epub 2006 Mar 7.
Minhua Shao, Jing Yuan, Liang Xu, Feng Wang, Yi Wang, Wentao Yuan, Ji Qian, Hongxia Ma, Ying Wang, Hongliang Liu, Weihong Chen, Lin Yang, Guangfu Jin, Xiang Huo, Feng Chen, Li Jin, Qingyi Wei, Wei Huang, Daru Lu, Tangchun Wu, Hongbing Shen
Affiliations
- PMID: 16522664
- DOI: 10.1093/carcin/bgi350
Polymorphisms in DNA damage binding protein 2 (DDB2) and susceptibility of primary lung cancer in the Chinese: a case-control study
Zhibin Hu et al. Carcinogenesis. 2006 Jul.
Abstract
DNA damage binding protein 2 (DDB2) is one of the major DNA repair proteins involved in the nucleotide excision repair (NER) pathway. Mutations in the DDB2 gene can cause a repair-deficiency syndrome xeroderma pigmentosum group E. Because tobacco carcinogens can cause DNA damage that is repaired by NER and suboptimal NER capacity is reported to be associated with lung cancer risk, we hypothesized that common variants in the DDB2 gene are associated with lung cancer risk. To test this hypothesis, we conducted a case-control study of 1010 patients with incident lung cancer and 1011 cancer-free controls and genotyped two DDB2 single nucleotide polymorphisms (SNPs) (rs830083 and rs3781620) that are in linkage disequilibrium with other untyped SNPs. We found that compared with the rs830083CC, subjects carrying the heterozygous rs830083CG genotype had a significantly 1.31-fold increased risk of lung cancer [95% confidence interval (CI) 1.08-1.60] and those carrying the homozygous rs830083GG genotype had a non-significantly 1.22-fold elevated risk (95% CI 0.89-1.67). In addition, effects of the combined rs830083CG/GG variant genotypes were more evident in young subjects, heavy smokers and subjects with a positive family history of cancer. These findings indicate, for the first time, that the DDB2 rs830083 polymorphism may contribute to the etiology of lung cancer. Further functional studies on this SNP and/or related variants are warranted to elucidate the underlying molecular mechanisms of the association.
Similar articles
- Polymorphisms in the two helicases ERCC2/XPD and ERCC3/XPB of the transcription factor IIH complex and risk of lung cancer: a case-control analysis in a Chinese population.
Hu Z, Xu L, Shao M, Yuan J, Wang Y, Wang F, Yuan W, Qian J, Ma H, Wang Y, Liu H, Chen W, Yang L, Jing G, Huo X, Chen F, Jin L, Wei Q, Wu T, Lu D, Huang W, Shen H. Hu Z, et al. Cancer Epidemiol Biomarkers Prev. 2006 Jul;15(7):1336-40. doi: 10.1158/1055-9965.EPI-06-0194. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16835333 - Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer.
Popanda O, Schattenberg T, Phong CT, Butkiewicz D, Risch A, Edler L, Kayser K, Dienemann H, Schulz V, Drings P, Bartsch H, Schmezer P. Popanda O, et al. Carcinogenesis. 2004 Dec;25(12):2433-41. doi: 10.1093/carcin/bgh264. Epub 2004 Aug 27. Carcinogenesis. 2004. PMID: 15333465 Clinical Trial. - Association of DNA repair gene XRCC1 and lung cancer susceptibility among nonsmoking Chinese women.
Yin J, Vogel U, Ma Y, Qi R, Wang H. Yin J, et al. Cancer Genet Cytogenet. 2009 Jan 1;188(1):26-31. doi: 10.1016/j.cancergencyto.2008.08.013. Cancer Genet Cytogenet. 2009. PMID: 19061777 - Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis.
Kiyohara C, Takayama K, Nakanishi Y. Kiyohara C, et al. Lung Cancer. 2006 Dec;54(3):267-83. doi: 10.1016/j.lungcan.2006.08.009. Epub 2006 Sep 18. Lung Cancer. 2006. PMID: 16982113 Review. - XRCC1 polymorphism and lung cancer risk.
Schneider J, Classen V, Helmig S. Schneider J, et al. Expert Rev Mol Diagn. 2008 Nov;8(6):761-80. doi: 10.1586/14737159.8.6.761. Expert Rev Mol Diagn. 2008. PMID: 18999926 Review.
Cited by
- Investigation of Polymorphisms in Global Genome Repair Genes in Patients With Ovarian Cancer in the Turkish Population.
Barham SY, Omotade D, Yılmaz S, Akdeniz FT, Goralı BÇ, Attar R, İsbir T. Barham SY, et al. Cancer Control. 2024 Jan-Dec;31:10732748241270597. doi: 10.1177/10732748241270597. Cancer Control. 2024. PMID: 39090825 Free PMC article. - Exploring COVID-19 causal genes through disease-specific Cis-eQTLs.
Zhang S, Wang P, Shi L, Wang C, Zhu Z, Qi C, Xie Y, Yuan S, Cheng L, Yin X, Zhang X. Zhang S, et al. Virus Res. 2024 Apr;342:199341. doi: 10.1016/j.virusres.2024.199341. Epub 2024 Feb 25. Virus Res. 2024. PMID: 38403000 Free PMC article. - Association between Single-Nucleotide Polymorphism in MicroRNA Target Site of DDB2 and Risk of Hepatocellular Carcinoma in a Southern Chinese Population.
Qiu M, Liu Y, Zhou Z, Jiang Y, Lin Q, Huo R, Liang X, Yu X, Zhou X, Yu H. Qiu M, et al. Biomed Res Int. 2020 Feb 8;2020:8528747. doi: 10.1155/2020/8528747. eCollection 2020. Biomed Res Int. 2020. PMID: 32090112 Free PMC article. - Precision oncology of lung cancer: genetic and genomic differences in Chinese population.
Shen H, Zhu M, Wang C. Shen H, et al. NPJ Precis Oncol. 2019 May 3;3:14. doi: 10.1038/s41698-019-0086-1. eCollection 2019. NPJ Precis Oncol. 2019. PMID: 31069257 Free PMC article. Review. - Single nucleotide polymorphisms of nucleotide excision repair pathway are significantly associated with outcomes of platinum-based chemotherapy in lung cancer.
Song X, Wang S, Hong X, Li X, Zhao X, Huai C, Chen H, Gao Z, Qian J, Wang J, Han B, Bai C, Li Q, Wu J, Lu D. Song X, et al. Sci Rep. 2017 Sep 18;7(1):11785. doi: 10.1038/s41598-017-08257-7. Sci Rep. 2017. PMID: 28924235 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical